Envista (NYSE:NVST) Receives Hold Rating from Needham & Company LLC

Needham & Company LLC reiterated their hold rating on shares of Envista (NYSE:NVST) in a research report sent to investors on Thursday morning, Benzinga reports.

Several other equities research analysts have also recently issued reports on NVST. Piper Sandler lowered their price objective on Envista from $18.00 to $16.00 and set a “neutral” rating on the stock in a report on Tuesday, July 30th. Robert W. Baird increased their price objective on Envista from $17.00 to $22.00 and gave the company a “neutral” rating in a research note on Thursday. Evercore ISI lifted their target price on shares of Envista from $18.00 to $23.00 and gave the stock an “outperform” rating in a research note on Monday, September 23rd. Leerink Partners raised shares of Envista from an “underperform” rating to a “market perform” rating and upped their target price for the stock from $16.00 to $23.00 in a report on Thursday. Finally, Stifel Nicolaus raised their price target on shares of Envista from $18.00 to $21.00 and gave the stock a “buy” rating in a research note on Wednesday, October 23rd. One investment analyst has rated the stock with a sell rating, eleven have assigned a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and an average price target of $20.71.

Envista Stock Down 0.1 %

NVST stock opened at $20.94 on Thursday. Envista has a one year low of $15.15 and a one year high of $25.64. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.90 and a current ratio of 2.08. The firm’s fifty day moving average is $18.64 and its 200 day moving average is $18.06. The firm has a market cap of $3.60 billion, a PE ratio of -2.69 and a beta of 1.30.

Envista (NYSE:NVST) last announced its quarterly earnings results on Wednesday, October 30th. The company reported $0.12 earnings per share for the quarter, beating the consensus estimate of $0.09 by $0.03. The firm had revenue of $601.00 million during the quarter, compared to analyst estimates of $590.34 million. Envista had a positive return on equity of 3.76% and a negative net margin of 53.42%. Envista’s revenue for the quarter was down 4.8% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.43 EPS. On average, research analysts forecast that Envista will post 0.7 EPS for the current year.

Insider Transactions at Envista

In other news, CFO Eric D. Hammes bought 24,532 shares of the stock in a transaction that occurred on Monday, August 12th. The stock was bought at an average cost of $16.33 per share, for a total transaction of $400,607.56. Following the acquisition, the chief financial officer now directly owns 24,532 shares of the company’s stock, valued at $400,607.56. The purchase was disclosed in a filing with the SEC, which is available at the SEC website. Company insiders own 1.30% of the company’s stock.

Institutional Investors Weigh In On Envista

A number of hedge funds have recently added to or reduced their stakes in the business. Mirae Asset Global Investments Co. Ltd. acquired a new position in shares of Envista during the third quarter worth $31,000. GAMMA Investing LLC increased its stake in Envista by 69.8% in the third quarter. GAMMA Investing LLC now owns 1,766 shares of the company’s stock valued at $35,000 after purchasing an additional 726 shares during the last quarter. Blue Trust Inc. raised its holdings in Envista by 69.7% during the third quarter. Blue Trust Inc. now owns 1,957 shares of the company’s stock worth $39,000 after purchasing an additional 804 shares in the last quarter. Allspring Global Investments Holdings LLC lifted its position in shares of Envista by 50.8% during the 3rd quarter. Allspring Global Investments Holdings LLC now owns 2,161 shares of the company’s stock worth $43,000 after buying an additional 728 shares during the last quarter. Finally, Versant Capital Management Inc boosted its holdings in shares of Envista by 1,420.3% in the 2nd quarter. Versant Capital Management Inc now owns 3,147 shares of the company’s stock valued at $52,000 after buying an additional 2,940 shares in the last quarter.

Envista Company Profile

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.